Talphera, Inc.
US ˙ NasdaqGM ˙ US00444T2096
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityACRX / Talphera, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership57,173 shares
Latest Disclosed Value $ 65,177
Group One Trading, L.p. ownership in ACRX / Talphera, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 57,173 shares of Talphera, Inc. (US:ACRX) valued at $65,177 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 30,415 shares of Talphera, Inc.. This represents a change in shares of 87.98% during the quarter. The current value of the position is $49,169 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ACRX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ACRX / Talphera, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F TALPHERA COM NEW 00444T209 57,173 26,758 87.98 65 140.74 0.0001
2025-11-12 2025-09-30 13F TALPHERA COM NEW 00444T209 30,415 30,400 202,666.67 27 0.0000
2025-08-14 2025-06-30 13F TALPHERA COM NEW 00444T209 15 0 0.00 0 0.0000
2025-05-14 2025-03-31 13F TALPHERA COM NEW 00444T209 15 -785 -98.12 0 0.0000
2025-05-14 2024-12-31 13F/A-1 TALPHERA COM NEW 00444T209 800 -934 -53.86 0 -100.00 0.0000
2025-02-14 2024-12-31 13F TALPHERA COM NEW 00444T209 800 -934 0 0.0000
2024-11-14 2024-09-30 13F TALPHERA COM NEW 00444T209 1,734 0 0.00 1 0.00 0.0000
2024-08-14 2024-06-30 13F TALPHERA COM NEW 00444T209 1,734 411 31.07 2 0.00 0.0000
2024-05-10 2024-03-31 13F TALPHERA COM NEW 00444T209 1,323 -2,355 -64.03 1 -50.00 0.0000
2024-02-14 2023-12-31 13F ACELRX PHARMACEUTICALS COM NEW 00444T209 3,678 3,678 3 0.0000
2023-08-09 2023-06-30 13F ACELRX PHARMACEUTICALS COM NEW 00444T209 0 -10 -100.00 0 0.0000
2023-05-12 2023-03-31 13F ACELRX PHARMACEUTICALS COM NEW 00444T209 10 -133 -93.01 0 0.0000
2023-02-09 2022-12-31 13F ACELRX PHARMACEUTICALS COM NEW 00444T209 143 143 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-11 2022-03-31 13F ACELRX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-11 2021-12-31 13F ACELRX PHARMACEUTICALS COM Call 1,000 -95.31 1 -95.45 n/a n/a n/a
2021-11-12 2021-09-30 13F ACELRX PHARMACEUTICALS COM Call 21,300 -91.84 22 -93.89 n/a n/a n/a
2021-08-10 2021-06-30 13F ACELRX PHARMACEUTICALS COM Call 261,100 -18.41 360 -33.82 n/a n/a n/a
2021-05-12 2021-03-31 13F ACELRX PHARMACEUTICALS COM Call 320,000 211.28 544 328.35 n/a n/a n/a
2021-02-10 2020-12-31 13F ACELRX PHARMACEUTICALS COM Call 102,800 -5.77 127 -18.06 n/a n/a n/a
2020-11-12 2020-09-30 13F ACELRX PHARMACEUTICALS COM Call 109,100 234.66 155 297.44 n/a n/a n/a
2020-08-13 2020-06-30 13F ACELRX PHARMACEUTICALS COM Call 32,600 39 n/a n/a n/a
2020-05-12 2020-03-31 13F ACELRX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F ACELRX PHARMACEUTICALS COM Call 82,000 -23.51 173 -26.69 n/a n/a n/a
2019-11-12 2019-09-30 13F ACELRX PHARMACEUTICALS COM Call 107,200 31.21 236 14.01 n/a n/a n/a
2019-08-09 2019-06-30 13F ACELRX PHARMACEUTICALS COM Call 81,700 -44.31 207 -59.49 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ACELRX PHARMACEUTICALS COM Call 146,700 106.91 511 211.59 n/a n/a n/a
2019-05-13 2019-03-31 13F ACELRX PHARMACEUTICALS COM Call 146,700 511 n/a n/a n/a
2019-02-05 2018-12-31 13F ACELRX PHARMACEUTICALS COM Call 70,900 -59.30 164 -75.56 n/a n/a n/a
2018-11-08 2018-09-30 13F ACELRX PHARMACEUTICALS COM Call 174,200 305.12 671 362.76 n/a n/a n/a
2018-08-13 2018-06-30 13F ACELRX PHARMACEUTICALS COM Call 43,000 -62.67 145 -40.08 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ACELRX PHARMACEUTICALS COM Call 115,200 118.18 242 126.17 n/a n/a n/a
2018-05-10 2018-03-31 13F ACELRX PHARMACEUTICALS COM Call 115,200 242 n/a n/a n/a
2018-02-09 2017-12-31 13F ACELRX PHARMACEUTICALS COM Call 52,800 247.37 107 52.86 n/a n/a n/a
2017-11-15 2017-09-30 13F ACELRX PHARMACEUTICALS COM Call 15,200 -9.52 70 94.44 n/a n/a n/a
2017-08-14 2017-06-30 13F ACELRX PHARMACEUTICALS COM Call 16,800 572.00 36 350.00 n/a n/a n/a
2017-05-10 2017-03-31 13F ACELRX PHARMACEUTICALS COM Call 2,500 8 n/a n/a n/a
2017-02-15 2016-12-31 13F ACELRX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F ACELRX PHARMACEUTICALS COM Call 700 0.00 3 n/a n/a n/a
2016-08-12 2016-06-30 13F ACELRX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-12 2016-03-31 13F ACELRX PHARMACEUTICALS COM Call 13,100 -35.47 40 -48.72 n/a n/a n/a
2016-02-11 2015-12-31 13F ACELRX PHARMACEUTICALS COM Call 20,300 -68.48 78 -60.20 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ACELRX PHARMACEUTICALS COM Call 64,400 -23.42 196 -45.10 n/a n/a n/a
2015-11-06 2015-09-30 13F ACELRX PHARMACEUTICALS COM Call 64,400 196 n/a n/a n/a
2015-08-11 2015-06-30 13F ACELRX PHARMACEUTICALS COM Call 84,100 164.47 357 190.24 n/a n/a n/a
2015-05-14 2015-03-31 13F ACELRX PHARMACEUTICALS COM Call 31,800 218.00 123 83.58 n/a n/a n/a
2015-02-11 2014-12-31 13F ACELRX PHARMACEUTICALS COM Call 10,000 -61.69 67 -53.15 n/a n/a n/a
2014-10-31 2014-09-30 13F ACELRX PHARMACEUTICALS COM Call 26,100 -14.71 143 -54.46 n/a n/a n/a
2014-08-12 2014-06-30 13F ACELRX PHARMACEUTICALS COM Call 30,600 -36.91 314 -46.05 n/a n/a n/a
2014-05-07 2014-03-31 13F ACELRX PHARMACEUTICALS COM Call 48,500 77.66 582 88.35 n/a n/a n/a
2014-01-31 2013-12-31 13F ACELRX PHARMACEUTICALS COM Call 27,300 120.16 309 130.60 n/a n/a n/a
2013-11-15 2013-09-30 13F ACELRX PHARMACEUTICALS COM Call 12,400 1,140.00 134 1,388.89 n/a n/a n/a
2013-08-02 2013-06-30 13F ACELRX PHARMACEUTICALS COM Call 1,000 9 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-11 2022-03-31 13F ACELRX PHARMACEUTICALS COM Put 0 -100.00 0 n/a n/a n/a
2022-02-11 2021-12-31 13F ACELRX PHARMACEUTICALS COM Put 600 200.00 0 n/a n/a n/a
2021-11-12 2021-09-30 13F ACELRX PHARMACEUTICALS COM Put 200 -92.00 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F ACELRX PHARMACEUTICALS COM Put 2,500 -77.06 3 -84.21 n/a n/a n/a
2021-05-12 2021-03-31 13F ACELRX PHARMACEUTICALS COM Put 10,900 -54.77 19 -36.67 n/a n/a n/a
2021-02-10 2020-12-31 13F ACELRX PHARMACEUTICALS COM Put 24,100 -30.14 30 -38.78 n/a n/a n/a
2020-11-12 2020-09-30 13F ACELRX PHARMACEUTICALS COM Put 34,500 75.13 49 104.17 n/a n/a n/a
2020-08-13 2020-06-30 13F ACELRX PHARMACEUTICALS COM Put 19,700 -39.01 24 -36.84 n/a n/a n/a
2020-05-13 2020-03-31 13F ACELRX PHARMACEUTICALS COM Put 32,300 -48.40 38 -71.21 n/a n/a n/a
2020-02-10 2019-12-31 13F ACELRX PHARMACEUTICALS COM Put 62,600 98.73 132 91.30 n/a n/a n/a
2019-11-12 2019-09-30 13F ACELRX PHARMACEUTICALS COM Put 31,500 12.90 69 -2.82 n/a n/a n/a
2019-08-09 2019-06-30 13F ACELRX PHARMACEUTICALS COM Put 27,900 -46.03 71 -60.56 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ACELRX PHARMACEUTICALS COM Put 51,700 -84.61 180 -76.80 n/a n/a n/a
2019-05-13 2019-03-31 13F ACELRX PHARMACEUTICALS COM Put 51,700 180 n/a n/a n/a
2019-02-05 2018-12-31 13F ACELRX PHARMACEUTICALS COM Put 336,000 231.69 776 98.97 n/a n/a n/a
2018-11-08 2018-09-30 13F ACELRX PHARMACEUTICALS COM Put 101,300 2.12 390 16.42 n/a n/a n/a
2018-08-13 2018-06-30 13F ACELRX PHARMACEUTICALS COM Put 99,200 3,206.67 335 5,483.33 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ACELRX PHARMACEUTICALS COM Put 3,000 -69.70 6 -70.00 n/a n/a n/a
2018-05-10 2018-03-31 13F ACELRX PHARMACEUTICALS COM Put 3,000 6 n/a n/a n/a
2018-02-09 2017-12-31 13F ACELRX PHARMACEUTICALS COM Put 9,900 135.71 20 5.26 n/a n/a n/a
2017-11-15 2017-09-30 13F ACELRX PHARMACEUTICALS COM Put 4,200 -84.15 19 -66.67 n/a n/a n/a
2017-08-14 2017-06-30 13F ACELRX PHARMACEUTICALS COM Put 26,500 12.77 57 -22.97 n/a n/a n/a
2017-05-10 2017-03-31 13F ACELRX PHARMACEUTICALS COM Put 23,500 770.37 74 957.14 n/a n/a n/a
2017-02-15 2016-12-31 13F ACELRX PHARMACEUTICALS COM Put 2,700 -64.00 7 -75.86 n/a n/a n/a
2016-11-14 2016-09-30 13F ACELRX PHARMACEUTICALS COM Put 7,500 650.00 29 866.67 n/a n/a n/a
2016-08-12 2016-06-30 13F ACELRX PHARMACEUTICALS COM Put 1,000 0.00 3 0.00 n/a n/a n/a
2016-05-12 2016-03-31 13F ACELRX PHARMACEUTICALS COM Put 1,000 400.00 3 200.00 n/a n/a n/a
2016-02-11 2015-12-31 13F ACELRX PHARMACEUTICALS COM Put 200 -99.58 1 -99.32 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ACELRX PHARMACEUTICALS COM Put 48,000 -3.03 146 -30.48 n/a n/a n/a
2015-11-06 2015-09-30 13F ACELRX PHARMACEUTICALS COM Put 48,000 146 n/a n/a n/a
2015-08-11 2015-06-30 13F ACELRX PHARMACEUTICALS COM Put 49,500 1,962.50 210 2,233.33 n/a n/a n/a
2015-05-14 2015-03-31 13F ACELRX PHARMACEUTICALS COM Put 2,400 -46.67 9 -70.00 n/a n/a n/a
2015-02-11 2014-12-31 13F ACELRX PHARMACEUTICALS COM Put 4,500 -90.38 30 -88.33 n/a n/a n/a
2014-10-31 2014-09-30 13F ACELRX PHARMACEUTICALS COM Put 46,800 52.94 257 -18.15 n/a n/a n/a
2014-08-12 2014-06-30 13F ACELRX PHARMACEUTICALS COM Put 30,600 5.88 314 -9.51 n/a n/a n/a
2014-05-07 2014-03-31 13F ACELRX PHARMACEUTICALS COM Put 28,900 36.97 347 45.19 n/a n/a n/a
2014-01-31 2013-12-31 13F ACELRX PHARMACEUTICALS COM Put 21,100 8.21 239 13.81 n/a n/a n/a
2013-11-15 2013-09-30 13F ACELRX PHARMACEUTICALS COM Put 19,500 178.57 210 223.08 n/a n/a n/a
2013-08-02 2013-06-30 13F ACELRX PHARMACEUTICALS COM Put 7,000 65 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.